⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL514440 | 1.00 | — | — | |
| SCHEMBL13716823 | 1.00 | — | — | |
| Fluoride SCHEMBL778559 | 0.95 | — | — | |
| SCHEMBL6912238 | 0.76 | — | — | |
| SCHEMBL23899535 | 0.73 | — | — | |
| SCHEMBL18710248 | 0.73 | — | — | |
| SCHEMBL5687715 | 0.73 | — | — | |
| SCHEMBL14349892 | 0.70 | — | — | |
| SCHEMBL516140 | 0.70 | — | — | |
| SCHEMBL776440 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230219890-A1 | BICYCLIC COMPOUNDS AND USE THEREOF | BETTA PHARMACEUTICALS CO LTD (CN) | 2023-07-13 | — | — | US | disclosed |
| US-20170253580-A1 | ORGANIC REACTIONS | THE ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2017-09-07 | — | — | US | disclosed |
| WO-2017124087-A1 | ANTI-PARASITIC COMPOUNDS AND USES THEREOF | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2017-07-20 | — | — | WO | disclosed |
| US-9365588-B2 | Benzoxazines as modulators of ion channels | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2016-06-14 | — | — | US | disclosed |
| WO-2016014426-A1 | ORGANIC REACTIONS | THE ARIZONA BOARD OF REGENTS (US) | 2016-01-28 | — | — | WO | disclosed |
| US-9163011-B2 | Oxazine derivatives and their use in the treatment of disease | NOVARTIS AG (CH) | 2015-10-20 | — | — | US | disclosed |
| US-9079861-B2 | Cyclic urea inhibitors of 11β-hydroxysteroid dehydrogenase 1 | VITAE PHARMACEUTICALS, INC. (US) | 2015-07-14 | — | — | US | disclosed |
| US-20140309220-A1 | BENZOXAZINES AS MODULATORS OF ION CHANNELS | VERTEX PHARMACEUTICALS INCORPORATED | 2014-10-16 | — | — | US | disclosed |
| WO-2014141104-A1 | 3-PYRIMIDIN-4-YL-OXAZOLIDIN-2-ONES AS INHIBITORS OF MUTANT IDH | NOVARTIS AG (CH) | 2014-09-18 | — | — | WO | disclosed |
| US-8722727-B2 | Antifungal agents | Seynix, Inc. (US) | 2014-05-13 | — | — | US | disclosed |
| US-20090208413-A1 | Registry Method and Control System for Dea Schedule II-V Medicines | DR PHARMA NOVA, LLC | 2009-08-20 | — | — | US | disclosed |
| US-20070293682-A1 | Methods of Preparing Sulfinamides and Sulfoxides | APSINTERM, LLC | 2007-12-20 | — | — | US | disclosed |
| US-20070293682-A1 | Methods of Preparing Sulfinamides and Sulfoxides | APSINTERM, LLC | 2007-12-20 | — | — | US | disclosed |
| US-7256297-B2 | Methods of preparing sulfinamides and sulfoxides | APSINTERM, LLC. (US) | 2007-08-14 | — | — | US | disclosed |
| US-7256297-B2 | Methods of preparing sulfinamides and sulfoxides | APSINTERM, LLC. (US) | 2007-08-14 | — | — | US | disclosed |
| US-7064214-B2 | Methods of preparing sulfinamides and sulfoxides | APSINTERM LLC (US) | 2006-06-20 | — | — | US | disclosed |
| US-20060128767-A1 | Methods of preparing sulfinamides and sulfoxides | SENANAYAKE CHRIS H | 2006-06-15 | — | — | US | disclosed |
| EP-1389184-A2 | METHODS OF PREPARING SULFINAMIDE AND SULFOXIDES | Apsinterm, LLC. (US) | 2004-02-18 | — | — | EP | disclosed |
| US-20030083517-A1 | Methods of preparing sulfinamides and sulfoxides | APSINTERM LLC | 2003-05-01 | — | — | US | disclosed |
| WO-2002083608-A2 | METHODS OF PREPARING SULFINAMIDE AND SULFOXIDES | APSINTERM LLC (US) | 2002-10-24 | — | — | WO | disclosed |